Relapsed and/or refractory multiple myeloma

Clinical trials for Relapsed and/or refractory multiple myeloma explained in plain language.

Never miss a new study

Get alerted when new Relapsed and/or refractory multiple myeloma trials appear

Sign up with your email to follow new studies for Relapsed and/or refractory multiple myeloma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 2 Not yet finished but already full! 1 Terminated 2

Promising myeloma combo trial pulled before it began

Disease control Cancelled

This study aimed to test a new drug called TAK-573, given with steroids and other cancer drugs, for people with multiple myeloma that came back or didn't respond to treatment. The goal was to find a safe dose and see if it helps shrink tumors. However, the trial was withdrawn bef…

Matched conditions: RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA

Phase 1 • Sponsor: Teva Branded Pharmaceutical Products R&D LLC • Aim: Disease control

Last updated Jun 27, 2026 08:11 UTC

Relapsed and/or refractory multiple myeloma

Get alerted when new Relapsed and/or refractory multiple myeloma trials appear

Promising myeloma combo trial pulled before it began